Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 6)


  • A.E. Abaturov State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro, Ukraine http://orcid.org/0000-0001-6291-5386
  • A.P. Volosovets Bogomolets National Medical University, Kyiv, Ukraine
  • T.P. Borysova State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro, Ukraine




diseases of the respiratory system, antioxidant system, drug management, review


The review of the literature presents mo­dern data on antioxidant and anti-inflammatory acti­vity of polyphenols, as well as their representatives curcumin and resveratrol in diseases of the respiratory system.


Abaturov AE, Volosovets AP, Borysova TP. Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 1). Zdorov`e rebenka. 2018;13(2):232-240. doi: 10.22141/2224-0551.13.2.2018.129558. (in Russian).

Abaturov AE, Volosovets AP, Borysova TP. Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 2). Zdorov`e rebenka. 2018;13(3):334-337. doi: 10.22141/2224-0551.13.3.2018.132918. (in Russian).

Abaturov AE, Volosovets AP, Borysova TP. Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 3). Zdorov`e rebenka. 2018;13(5):539-544. doi: 10.22141/2224-0551.13.5.2018.141574. (in Russian).

Abaturov AE, Volosovets AP, Borysova TP. Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 4). Zdorov`e rebenka. 2018;13(6):616-620. doi: 10.22141/2224-0551.13.5.2018.143169. (in Russian).

Abaturov AE, Volosovets AP, Borysova TP. Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 5). Zdorov`e rebenka. 2018;13(7):710-716. doi: 10.22141/2224-0551.13.7.2018.148926. (in Russian).

Chervyakovsky EM, Kurchenko VP, Kostyuk VA. The role of flavonoids in biological reactions with electron transfer. Works of the Belarusian State University. 2009;4(1). Available from: http://www.bio.bsu.by/proceedings/?act=7&id=1. (in Russian).

Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009 Feb;30(2):85-94. doi: 10.1016/j.tips.2008.11.002.

Zhang D, Huang C, Yang C, Liu RJ, Wang J, Niu J, Brömme D. Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respir Res. 2011 Nov 29;12:154. doi: 10.1186/1465-9921-12-154.

Karaman M, Firinci F, Cilaker S, et al. Anti-inflammatory effects of curcumin in a murine model of chronic asthma. Allergol Immunopathol (Madr). 2012 Jul-Aug;40(4):210-4. doi: 10.1016/j.aller.2011.04.006.

Frombaum M, Le Clanche S, Bonnefont-Rousselot D, Borderie D. Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases. Biochimie. 2012 Feb;94(2):269-76. doi: 10.1016/j.biochi.2011.11.001.

Barnes PJ. Histone deacetylase-2 and airway disease. Ther Adv Respir Dis. 2009 Oct;3(5):235-43. doi: 10.1177/1753465809348648.

Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 2010 May 31;120(2-3):76-85. doi: 10.1016/j.jsbmb.2010.02.018.

Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol. 2011 May;163(1):29-43. doi: 10.1111/j.1476-5381.2010.01199.x.

Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011 Jun 3;16(6):4567-98. doi: 10.3390/molecules16064567.

Sarna LK, Wu N, Hwang SY, Siow YL, O K. Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages. Can J Physiol Pharmacol. 2010 Mar;88(3):369-78. doi: 10.1139/Y09-136.

Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 2003 Oct 1;171(7):3863-71.

Gupta SC, Kannappan R, Reuter S, Kim JH, Aggarwal BB. Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci. 2011 Jan;1215:150-60. doi: 10.1111/j.1749-6632.2010.05852.x.

Cheynier V. Polyphenols in foods are more complex than often thought. Am J Clin Nutr. 2005 Jan;81(1 Suppl):223S-229S. doi: 10.1093/ajcn/81.1.223S.

Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin--from molecule to biological function. Angew Chem Int Ed Engl. 2012 May 29;51(22):5308-32. doi: 10.1002/anie.201107724.

Kumar D, Kumar M, Saravanan C, Singh SK. Curcumin: a potential candidate for matrix metalloproteinase inhibitors. Expert Opin Ther Targets. 2012 Oct;16(10):959-72. doi: 10.1517/14728222.2012.710603.

Xiao X, Yang M, Sun D, Sun S. Curcumin protects against sepsis-induced acute lung injury in rats. J Surg Res. 2012 Jul;176(1):e31-9. doi: 10.1016/j.jss.2011.11.1032.

Sakurai R, Li Y, Torday JS, Rehan VK. Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling. Am J Physiol Lung Cell Mol Physiol. 2011 Nov;301(5):L721-30. doi: 10.1152/ajplung.00076.2011.

Lee JH, Kim JW, Ko NY, et al. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J Allergy Clin Immunol. 2008 May;121(5):1225-31. doi: 10.1016/j.jaci.2007.12.1160.

de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans. 2007 Nov;35(Pt 5):1156-60. doi: 10.1042/BST0351156.

Allard JS, Perez E, Zou S, de Cabo R. Dietary activators of Sirt1. Mol Cell Endocrinol. 2009 Feb 5;299(1):58-63. doi: 10.1016/j.mce.2008.10.018.

Dragsted LO. Antioxidant actions of polyphenols in humans. Int J Vitam Nutr Res. 2003 Mar;73(2):112-9. doi: 10.1024/0300-9831.73.2.112.

Duracková Z. Some current insights into oxidative stress. Physiol Res. 2010;59(4):459-69.

Dündar Y, Aslan R. Antioxidative stress. Eastern J Med. 2000;5(2):45-47.

Wang W, Zhu R, Xie Q, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine. 2012;7:3667-77. doi: 10.2147/IJN.S30428.

Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr. 2010 Jun;103(11):1545-57. doi: 10.1017/S0007114509993667.

Es-Safi NE, Ghidouche S, Ducrot PH. Flavonoids: hemisynthesis, reactivity, characterization and free radical scavenging activity. Molecules. 2007 Sep 26;12(9):2228-58.

Gaston B. The biochemistry of asthma. Biochim Biophys Acta. 2011 Nov;1810(11):1017-24. doi: 10.1016/j.bbagen.2011.06.008.

Guo JJ, Hsieh HY, Hu CH. Chain-breaking activity of carotenes in lipid peroxidation: a theoretical study. J Phys Chem B. 2009 Nov 26;113(47):15699-708. doi: 10.1021/jp907822h.

Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys. 2008 Aug 15;476(2):107-12. doi: 10.1016/j.abb.2008.01.028.

Hou DX, Kumamoto T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid Redox Signal. 2010 Sep 1;13(5):691-719. doi: 10.1089/ars.2009.2816.

Hu ML. Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. Chang Gung Med J. 2011 Sep-Oct;34(5):449-60.

Kurup VP, Barrios CS, Raju R, Johnson BD, Levy MB, Fink JN. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy. 2007 Jan 25;5:1. doi: 10.1186/1476-7961-5-1.

Kennedy DO, Wightman EL. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr. 2011 Jan;2(1):32-50. doi: 10.3945/an.110.000117.

Khalatbary AR, Zarrinjoei GR. Anti-inflammatory effect of oleuropein in experimental rat spinal cord trauma. Iran Red Crescent Med J. 2012 Apr;14(4):229-34.

Kim DH, Phillips JF, Lockey RF. Oral curcumin supplementation in patients with atopic asthma. Allergy Rhinol (Providence). 2011 Apr;2(2):e51-3. doi: 10.2500/ar.2011.2.0016.

Kovacic P, Somanathan R. Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev. 2010 Mar-Apr;3(2):86-100. doi: 10.4161/oxim.3.2.11147.

Kurup VP, Barrios CS. Immunomodulatory effects of curcumin in allergy. Mol Nutr Food Res. 2008 Sep;52(9):1031-9. doi: 10.1002/mnfr.200700293.

Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res. 2004 Aug;38(8):771-85.

Ortuño J, Covas MI, Farre M, et al. Matrix effects on the bioavailability of resveratrol in humans. Food Chemistry. 2010;4(120):1123-1130 doi: 10.1016/j.foodchem.2009.11.032.

Mullaicharam A.R., Maheswaran A. Pharmacological effects of curcumin. Int J Nutr Pharmacol Neurol Dis. 2012;2(2):92-99. doi: 10.4103/2231-0738.95930.

Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biol Pharm Bull. 2012;35(3):273-9.

Nemmar A, Subramaniyan D, Ali BH. Protective effect of curcumin on pulmonary and cardiovascular effects induced by repeated exposure to diesel exhaust particles in mice. PLoS One. 2012;7(6):e39554. doi: 10.1371/journal.pone.0039554.

Biswas S, Hwang JW, Kirkham PA, Rahman I. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. Curr Med Chem. 2013;20(12):1496-530.

Pirola L, Fröjdö S. Resveratrol: one molecule, many targets. IUBMB Life. 2008 May;60(5):323-32. doi: 10.1002/iub.47.

Davinelli S, Sapere N, Zella D, Bracale R, Intrieri M, Scapagnini G. Pleiotropic protective effects of phytochemicals in Alzheimer's disease. Oxid Med Cell Longev. 2012;2012:386527. doi: 10.1155/2012/386527.

Santangelo C, Varì R, Scazzocchio B, Di Benedetto R, Filesi C, Masella R. Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita. 2007;43(4):394-405.

Visioli F, De La Lastra CA, Andres-Lacueva C, et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr. 2011 Jul;51(6):524-46. doi: 10.1080/10408391003698677.

Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol. 2003 Jan 31;36(1):95-109.

Rahman I, Chung S. Dietary polyphenols, deacetylases and chromatin remodeling in inflammation. J Nutrigenet Nutrigenomics. 2010;3(4-6):220-30. doi: 10.1159/000324358.

Rahman I, Kinnula VL. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol. 2012 May;5(3):293-309. doi: 10.1586/ecp.12.16.

Ram A, Das M, Ghosh B. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull. 2003 Jul;26(7):1021-4.

Singh PP, Chandra A, Mahdi F, Roy A, Sharma P. Reconvene and reconnect the antioxidant hypothesis in human health and disease. Indian J Clin Biochem. 2010 Jul;25(3):225-43. doi: 10.1007/s12291-010-0078-y.

Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 2010 Sep 1;501(1):79-90. doi: 10.1016/j.abb.2010.05.003.

Hadi SM, Ullah MF, Azmi AS, et al. Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidativeDNA breakage: a putative mechanism for chemoprevention of cancer. Pharm Res. 2010 Jun;27(6):979-88. doi: 10.1007/s11095-010-0055-4.

Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol. 2012 Jul 17;3:141. doi: 10.3389/fphar.2012.00141. eCollection 2012.

Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L478-88. doi: 10.1152/ajplung.00361.2007.

Roy S, Sannigrahi S, Majumdar S, Ghosh B, Sarkar B. Resveratrol regulates antioxidant status, inhibits cytokine expression and restricts apoptosis in carbon tetrachloride induced rat hepatic injury. Oxid Med Cell Longev. 2011;2011:703676. doi: 10.1155/2011/703676.

Rice-Evans C. Flavonoid antioxidants. Curr Med Chem. 2001 Jun;8(7):797-807.

Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol. 2007;595:127-48. doi: 10.1007/978-0-387-46401-5_4.

Rajendran R, Garva R, Krstic-Demonacos M, Demonacos C. Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol. 2011;2011:368276. doi: 10.1155/2011/368276.

Spencer JP. Flavonoids: modulators of brain function? Br J Nutr. 2008 May;99 E Suppl 1:ES60-77. doi: 10.1017/S0007114508965776.

Spencer JP. Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain. Proc Nutr Soc. 2010 May;69(2):244-60. doi: 10.1017/S0029665110000054.

Narumoto O, Matsuo Y, Sakaguchi M, et al. Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling. Exp Mol Pathol. 2012 Aug;93(1):18-25. doi: 10.1016/j.yexmp.2012.04.011.

Švajger U, Jeras M. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int Rev Immunol. 2012 Jun;31(3):202-22. doi: 10.3109/08830185.2012.665108.

Timmers S, Auwerx J, Schrauwen P. The journey of resveratrol from yeast to human. Aging (Albany NY). 2012 Mar;4(3):146-58. doi: 10.18632/aging.100445.

Izzi V, Masuelli L, Tresoldi I, Sacchetti P, Modesti A, Galvano F, Bei R. The effects of dietary flavonoids on the regulation of redox inflammatory networks. Front Biosci (Landmark Ed). 2012 Jun 1;17:2396-418.

Watelet JB, Gillard M, Benedetti MS, Lelièvre B, Diquet B. Therapeutic management of allergic diseases. Drug Metab Rev. 2009;41(3):301-43. doi: 10.1080/10837450902891204.

Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010 Dec;2(12):1231-46. doi: 10.3390/nu2121231.

Turan B, Tuncay E, Vassort G. Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr. 2012 Apr;44(2):281-96. doi: 10.1007/s10863-012-9429-0.

Vauzour D. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev. 2012;2012:914273. doi: 10.1155/2012/914273.

Venkatesan N, Punithavathi D, Babu M. Protection from acute and chronic lung diseases by curcumin. Adv Exp Med Biol. 2007;595:379-405. doi: 10.1007/978-0-387-46401-5_17.

Villanueva C, Kross RD. Antioxidant-induced stress. Int J Mol Sci. 2012;13(2):2091-109. doi: 10.3390/ijms13022091.

Vang O, Ahmad N, Baile CA, et al. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One. 2011;6(6):e19881. doi: 10.1371/journal.pone.0019881.

Wood LG, Wark PA, Garg ML. Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal. 2010 Nov 15;13(10):1535-48. doi: 10.1089/ars.2009.3064.

Yao H, Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol. 2011 Jul 15;254(2):72-85. doi: 10.1016/j.taap.2009.10.022.

Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011 Mar 1;12(3):332-47.





Theoretical Medicine